The Truncated Gene cfaD′ Positively Regulates CFA/Ⅰ Expression of Enterotoxigenic Escherichia coli

The gene cluster cfaABCED’ of enterotoxigenic Escherichia coli, encoding the fimbriae which is called colonization factor antigen located on a plasmid. It is positively regulated by cfaR, a member of the AraC family, and the cfaD’ gene region, which is located downstream of cfaE and is homologous to cfaR, had been described as a truncated cryptic gene. In the present study we observed that the CFA/ fimbriae subunit, cfaB, was expressed in lower amount by the cfaABCED’ clone pNTP513 in host E. coli HB101. The expression of CFA/ diminished by deletion of cfaD’ gene region from pNTP513, and was restored by acquisition of cfaD’ in trans. Furthermore, CFA/ expression by cfaD’ deletion mutant, the cfaABCE clone, was remarkably increased by the presence of cfaD’ in trans in a topoisomerase A deficient strain of E. coli DM800. These data suggest that cfaD’ region is a functional region of gene, that regulates the CFA/ expression with cfaR by unknown mechanism.

An Improved Strategy for Efficient Expression and Purification of Soluble HIV-1 Tat Protein in E.coli

Although the endogenous function of Tat has been elucidated in the past twenty years, the study of its exogenous activity has been hampered due to the difficulty of large scale preparation of the active Tat protein. To express the full-length Tat protein in E.coli, the tat gene was cloned from an HIV infected patient by overlapping PCR. Rare codon usage analysis showed that rare E.coli codons, especially consecutive rare codons for Arg, account for 14% (14 of 101) rare E.coli codons in the tat gene. The expression of the HIV-1 tat gene was verified to be very poor in strain BL21 (DE3) due to the abundance of rare codons; however, tat gene expression was found to be very efficient in the host strain of Rosetta-gami B (DE3), which was supplemented with six rare tRNAs for Arg, Leu, Ile and Pro. Subsequent purification revealed that the proteins are soluble and unusually, the tagged Tat can form dimers independent of cystine disulfide bonds. The purity, integrity and molecular weight of the Tat protein were demonstrated by MALDI-TOF mass spectrometry. Reporter gene activating assay was further confirmed by investigating the transactivation activity of the recombinant Tat protein. Our improved strategy for efficient high level expression and purification of soluble Tat protein has paved the way to fully investigate its exogenous function.

Expression of Core Domain of Porcine Zona Pellucida 3β in E.coli

To obtain the recombinant core domain of porcine zone pellucida 3β （cZP3β） for the further research on its functions Methods The nucleotide sequence region from 44 to 306 codons of pZP3β entire eDNA was obtained by PCR and then was cloned into pET-3c vector. After being identified, recon was transformed into E.coli BL21 （DE3） pLysS and then induced by IPTG. Results The recombinant cZP3β was expressed in E. coli up to 15% of total cellular proteins, and was made sure by Western blot analysis. Conclusion The research on expression of core domain of pZP3β could benefit to further investigation of its immunogenicity and the development of antigen preparation.

Expression of the human era cDNA in E.coli

Objective: To amplify human era (Hera) gene, then express it in E.coli. Methods: Human era gene, after amplified by PCR and identified by sequencing, was inserted into the expression vector pGEX-4T3 in which exogenous gene was controlled by Ptac promoter. The recombinant plasmid pGEX-Hera was transformed into DH5 (and induced with IPTG chemically. Results: The human era gene was amplified and the sequence was correct. When the bacteria with pGEX-Hera was induced, an anticipated 65 000 protein band appeared on SDS-PAGE gel and amounted to 23% of total bacterial protein. Conclusion: The human era gene has been successfully amplified and efficiently expressed in E.coli.

EXPRESSION OF HBV PRE S1 PEPTIDE INE. Coli AND PRODUCT CHARACTERIZATION

HBV Pre S1 sequence is supposed to play an important role in the infection of HBV. Presence of Pre S1 /anti-Pre S1 in serum has valuble clinical imphations. In order to improve the study of Pre S1, Pre S1 sequence was overexpressed in E. coli as a fusion protein with MBP (Maltose- binding Protein), and anti-Pre S1 antiserum was elicited in rabbits by Pre S1 MBP purified by affinity chromatography. The recombinant plasmid constructed from PMAL-cRI expressed the 106aa Pre S1 sequence at the C terminal of MBP by tac promoter. The resulting Protein is about 54kD in size. Western-blot analysis confirmed its reactivity with antiserum derived from synthetic Pre S1 peptide and serum from patients with acute hepatitis B (AHB). ELISA showed that Pre S1-MBP and Dane Particles purified from AHB patient’s serum reacted with antiserum against synthetic Pre S1 peptlde,and this reaction was specifically inhibited by synthetic Pre S1 peptide. ELISA also demonstrated that antiserum against Pre S1-MBP reacted with synthetic Pre S1 peptide, but not with synthetic HCV peptide or HEV peptide.

Minimizing endogenous cryptic plasmids to construct antibiotic-free expression systems for Escherichia coli Nissle 1917

The probiotic bacterium Escherichia coli Nissle 1917(EcN)holds significant promise for use in clinical and biological industries.However,the reliance on antibiotics to maintain plasmid-borne genes has overshadowed its benefits.In this study,we addressed this issue by engineering the endogenous cryptic plasmids pMUT1 and pMUT2.The non-essential elements were removed to create more stable derivatives pMUT1NR△and pMUT2HBC△.Synthetic promoters by integrating binding motifs on sigma factors were further constructed and applied for expression of Bacteroides thetaiotaomicron heparinaseⅢand the biosynthesis of ectoine.Compared to traditional antibiotic-dependent expression systems,our newly constructed antibiotic-free expression systems offer considerable advantages for clinical and synthetic biology applications.

猪卵透明带-3β融合蛋白在E.coli中的表达和鉴定

对全长猪卵透明带－３β（ｐＺＰ３β）ｃＤＮＡ的５端重新测序分析，发现文献报道的该克隆基因５端非编码序列中漏读了两个碱基，继而选择符合ｐＺＰ３βｃＤＮＡ阅读框的ｐＷＲ４５０－２载体质粒，通过双酶切构建了β－半乳糖苷酶／ｐＺＰ３β融合蛋白基因的细菌表达质粒。转化宿主菌后用ＩＰＴＧ诱导，ＳＤＳ－ＰＡＧＥ分析表明ｐＺＰ３β融合蛋白在Ｅ．ｃｏｌｉ中获得表达，并在蛋白印迹鉴定中能同兔抗猪ＺＰＩｇＧ呈特异性免疫反应。

中国白兔白介素-15基因的克隆、序列分析及其在E.coli中的表达

以RT-PCR技术对用ConA刺激的中国白兔外周血淋巴细胞（PMBCr）进行扩增,将纯化后的PCR产物克隆入pMD18-T中进行核苷酸序列测定,并与不同物种的IL-15基因进行序列比较。结果IL-15基因全长489 bp,编码162个氨基酸,其中前29个氨基酸残基构成信号肽序列。与不同物种IL-15基因相比,核苷酸和推导的氨基酸序列有一定的差异。在推导的中国白兔IL-15氨基酸序列中,在108～110、119～121、127～129和143～146位存在4个潜在的N-联糖基化位点,同时存在6个Cys残基。将pTIL-15双酶切,回收目的基因片段克隆到大肠杆菌表达载体pET28a中构建了重组质粒pETIL-15,转化大肠杆菌BL21（DE3）,并用IPTG进行了诱导。结果重组菌菌体裂解物经SDS-PAGE电泳可检测到相对分子质量为20 500的重组目的蛋白。经凝胶薄层扫描,目的蛋白表达量可占菌体蛋白的13.6%。

E·coli木糖异构酶基因的克隆及表达条件的优化

采用PCR技术以大肠杆菌JM109基因组DNA为模板扩增得到木糖异构酶基因xylA,连接到载体pET-22b(+),得到重组质粒pET-22b(+)-xylA。将此重组质粒转化到大肠杆菌菌株BL21(DE3)中,重组菌株经IPTG诱导后,通过半胱氨酸-咔唑法测得木糖异构酶活力。每mL发酵液中重组菌株显示出酶活力约为0.84 U。SDS-PAGE电泳结果显示出明显的5×104(相对分子质量)特异性蛋白质条带。

内源性血管生成抑制因子A rresten在E.coli JM109中的表达及抗新生血管生成的药理学研究

目的构建内源性血管生成抑制因子Arresten基因的原核表达载体，并进行表达，抑制新生血管的药理学实验中发现，该表达产物具有抑制鸡胚绒毛尿囊膜血管生长的功能。方法从健康产妇的胎盘组织中提取总RNA，经逆转录-聚合酶链式反应（RT-PCR）扩增出Arresten基因，构建重组质粒pBV220-Art转化E．coli JM109进行原核表达，大量表达提取Arresten蛋白，用鸡胚绒毛尿囊膜实验进行活性测定。结果成功构建的重组质粒pBV220-Arr在E．coli JM109菌株中2～8h均可获得表达，其中诱导4h表达效率最高，Arresten蛋白可明显抑制鸡胚绒毛尿囊膜血管生长，活性功能明显强于血管抑素。结论成功构建Arresten基因重组质粒pBV220-Arr，并可在E．coli JM109菌株中获得表达，Arresten蛋白具有明显的抑制血管生成的作用。

E．coli分泌表达载体的构建和人表皮生长因子在E．coli中的分泌性表达

采用ＰＣＲ技术从Ｅ．ｃｏｌｉ基因组片段中克隆出碱性磷酸酯酶（ＰｈｏＡ）的启动子和信号肽序列．在ＰｈｏＡ启动予５＇端设计了ＥｃｏＲⅠ酶切位点，在信号肽编码序列３＇端设计了ＨｉｎｄⅢ酶切位点．将ＰＣＲ产物酶切后ＥｃｏＲⅠ－ＨｉｎｄⅢ片段克隆至ｐＢＲ３２２的ＥｃｏＲⅠ－ＨｉｎｄⅢ位点，组构出含有ＰｈｏＡ启动子和信号肽序列的分泌表达载体ｐＢＭ－Ｐｈｏ－１．之后将人表皮生长因子的成熟肽基因克隆至该载体，使之在Ｅ．ｃｏｌｉ中获得分泌表达，另采用ｐＩＮⅢ载体系统以分泌方式表达了人表皮生长因子。

利用噬菌体T＿7RNA聚合酶在大肠杆菌（E．coli）中引导人尿激酶原克隆基因的表达

我们将人尿激酶原基因（ｐｒｏ－ＵＫ）重组到含Ｔ＿７基因１０启动子的质粒（ｐＥＴ３ｃ）中，用异丙基硫代半乳糖苷（ＩＰＴＧ）诱导，在大肠杆菌（Ｅ．ｃｏｌｉ）的ＢＬ２１（ＤＥ３）菌株中进行表达。经纤维蛋白平板测活法测得表达产物存在于包含体中。经变性和复性处理后，表达量达每升培养液１６００ＩＵ．用ＷｅｓｔｅｒｎＢｌｏｔ法鉴定表达产物为单一条带。分子量在４３ｋＤａ左右，略低于天然５４ｋＤａｐｒｏ－ＵＫ。这可能与Ｅ．ｃｏｌｉ中缺乏糖基化酶有关。

用E.coli表达Canstatin-N及其表达条件优化

以重组质粒pET-CN为模板设计引物CASN1和CASN2,PCR方法扩增约267bp的人血管能抑素N端1～89氨基酸基因片段,用EcoR I和Sal I双酶切将其克隆进pET-22b(+)载体获得重组表达质粒pET-22b(+)-CN,转化E.coli BL21(DE3),用IPTG诱导表达Canstatin-N,产物以包涵体形式存在。本文在摇瓶发酵条件下研究了诱导剂浓度、诱导培养时间对目标蛋白表达的影响,结果表明IPTG的最佳诱导浓度为0.1mmol/L;37℃下诱导培养2h时产物表达量最高。纯化获得的融合his6的重组Canstatin-N具有免疫和抑制鸡胚绒毛尿囊膜(CAM)新生血管生成活性。

人胰岛素样生长因子Ⅰ型在E.coli和家蚕中的表达

将hIGF-I基因克隆进原核表达载体pET-28a(+),在E.coli中进行了融合表达,West-ern blotting显示在26 kD附近有一条特异条带。将hIGF-I基因克隆进pBacPAK-8,获得了杆状病毒转移载体pBacPAK-8-IGF-I,在脂质体的介导下,与线性化的家蚕杆状病毒共转染家蚕培养细胞Bm-N,经空斑筛选,PCR检测,获得了重组病毒Bm-Bac-hIGF-Ⅰ。SDS-PAGE检测表明,在感染重组病毒后,家蚕幼虫血淋巴中可以检测到一条分子量约为7.5 kD的特异性条带,ELISA检测表达量达4.51μg/mL蚕血淋巴。

大肠杆菌菌影制备及介导pEGFP-N1在RAW264.7细胞中表达

通过PCR扩增噬菌体PhiX174裂解基因E,并将其插入到温控表达载体pBV220中,构建重组温控表达质粒pBV220-E。将重组质粒pBV220-E转化至大肠杆菌DH5α中,升温到42℃诱导E基因的表达。将真核表达质粒pEGFP-N1与大肠杆菌菌影孵育后转染小鼠巨噬细胞RAW264.7,荧光显微镜观察pEGFP-N1的表达情况。结果表明:扩增的E基因全长为276bp,与GenBank公布的基因序列一致。电镜观察结果显示,细菌表面出现跨膜孔道,细菌内容物经孔道排出形成空壳。荧光显微镜观察结果显示,大肠杆菌菌影介导的pEGFP-N1在小鼠巨噬细胞中获得表达。为进一步研究以细菌菌影为基础的新型灭活疫苗和载体疫苗提供参考依据。

致猪水肿病大肠杆菌鄂E株菌毛F18基因FedF亚基的克隆、表达及其生物学特性

以致猪水肿病大肠杆菌鄂E株为模板,通过PCR的方法扩增大肠杆菌菌毛F18主要亚基FedF的全长及去信号肽亚基因FedFs,扩增片段分别为1000、900 bp。将纯化的扩增产物克隆到pMD18-T中,通过酶切鉴定和序列分析表明,含SacⅠ及HindⅢ酶切位点的基因全长为967 bp,鄂E株FedF基因编码区全长903 bp,编码301个氨基酸,碱基序列同标准株107/86的同源性为100%。与菌毛AF/R1相比,编码的蛋白质没有同源性。利用pGEX-KG分别构建表达载体,SDS-PAGE检测表明FedFc/pGEX-KG无表达带,FedFs/pGEX-KG则有约58 000的特异性表达带;West-ern blotting检测表明重组蛋白具有免疫原性。利用重组蛋白GST-FedF免疫新西兰兔所制备的抗血清,能抑制Ee株与刷状缘细胞的粘附。利用表达的蛋白建立了F18的ELISA检测方法,并检测790份临床送检血样,其中536份呈阳性,血清学阳性率为67.8%。结果表明,FedF是猪大肠杆菌病新型疫苗及F18+E.coli感染鉴别诊断的良好候选抗原,通过本试验建立的ELISA方法揭示国内的F18+E.coli感染严重,血清学阳性率高达67.8%。

Cloning and expression and purification of Hepatitis B e-antigen precursor in Escherichia coli

OBJECTIVE: To investigate the role of the 25 kD hepatitis B e antigen (HBeAg) precursor that only exist inside hepatocytes and study its effect on the pathopoiesis of hepatitis B and QIAGEN expression and purification system. METHODS: Hepatitis B virus (HBV) preC/C gene for the 25 kD HBeAg precursor was cloned into the expression vector pQE30 and the 25 kD HBeAg precursor was expressed in Escherichia coli (E. coli) and purified. Its antigenicity for 21 kD mature HBeAg was tested by western blot analysis. RESULTS: Cloned fragments in the expression vector were sequenced and verified to be homogeneous with that of HBV (ayw subtype). Expression of the HBeAg precursor in E. coli under the transcriptional regulation of T5 promoter yielded a soluble cytosolic protein with an apparent molecular mass of 25 kD. Recombinant HBeAg precursor exhibited identical potencies with 21 kD mature HBeAg that reacted with anti-HBeAg antibodies. The purification rate of the expressed HBeAg precursor was up to 89.6% and the yield of purified HBeAg precursor from this procedure was 2.4 mg/L. CONCLUSION: 25 kD HBeAg precursor exhibited biological activity and might play an important role in pathopoiesis of hepatitis B.

猪A组轮状病毒Vp7基因与双标记表达载体pW425et的重组及在大肠杆菌中的表达

以猪A组轮状病毒mRNA为模板,应用反转录聚合酶链式反应(RT-PCR)技术,扩增了981 bp的Vp7基因,通过T-A克隆技术,将PCR产物克隆至pGEM-T载体中,构建出克隆质粒pGEM-T-Vp7。以SacⅠ和KpnⅠ双酶切pGEM-T-Vp7及双标记表达载体pW425et,并将纯化的Vp7基因亚克隆至双标记表达载体pW425et中,构建出可以在乳酸菌与大肠杆菌之间穿梭表达的原核表达重组质粒pW425et-Vp7。将pW425et-Vp7转化至thyA基因缺陷型的大肠杆菌感受态Escherichia coliX13中,经生长功能弥补筛选阳性克隆和SDS-PAGE分析,可见约40 kD的融合蛋白。Western blot分析表明该蛋白具有与猪轮状病毒多克隆抗体的反应原性。

内源性血管生成抑制因子Arresten原核表达载体的构建及表达

目的构建内源性血管生成抑制因子Arresten基因的原核表达载体,并在E.coliDH5α进行表达。方法从健康产妇的胎盘组织中提取总RNA,经逆转录—聚合酶链式反应(RT-PCR)扩增出Arresten基因,构建重组质粒pBV220-Arr转化E.coliDH5α进行原核表达。结果成功筛选出Arresten基因并构建了重组质粒pBV220-Arr,重组质粒在菌株中获得表达。结论构建的原核表达重组体pBV220-Arr能高效表达重组Arresten蛋白。

猪2型圆环病毒间接ELISA检测方法研究

应用PCR扩增得到猪2型圆环病毒ORF2基因的3′端约600 bp,该PCV2 ORF2基因已去除终止子,并分别在其上下游添加Kpn Ⅰ和Hind Ⅲ酶切位点。PCR产物用Kpn Ⅰ和 Hind Ⅲ酶切后,与经同样处理过的 pBAD/g Ⅲ B Vector连接,转化TOP10细胞后挑取阳性克隆,经酶切鉴定和测序验证后用L-arabinose诱导进行融合表达,表达的蛋白主要以包涵体存在。经过镍离子亲和层析柱纯化,SDS-PAGE显示1条约28 ku的目的条带, 纯度达到85％以上。以该28 ku的多肽包被酶标板,建立了PCV2的间接ELISA检测方法。